Clariene SE [CLARI] vs Orpea [ORP] Detailed Stock Comparison

Clariene SE

Euronext
Loading...

Orpea

Euronext
Loading...

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Clariene SE wins in 4 metrics, Orpea wins in 9 metrics, with 0 ties. Orpea appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricClariene SEOrpeaBetter
P/E Ratio (TTM)9.760.10Orpea
Price-to-Book Ratio0.42N/AN/A
Debt-to-Equity Ratio209.584.85Orpea
PEG Ratio53.05N/AN/A
EV/EBITDA7.142.94Orpea
Profit Margin (TTM)-1.16%79.36%Orpea
Operating Margin (TTM)3.80%38.13%Orpea
EBITDA Margin (TTM)3.80%38.13%Orpea
Return on Equity-1.54%71.75%Orpea
Return on Assets (TTM)1.34%9.74%Orpea
Free Cash Flow (TTM)$600.10M$225.10MClariene SE
1-Year Return135.96%89.29%Clariene SE
Price-to-Sales Ratio (TTM)0.290.37Clariene SE
Enterprise Value$9.32B$10.46BOrpea
EV/Revenue Ratio1.762.01Clariene SE
Revenue per Share (TTM)$15N/AN/A
Earnings per Share (Diluted)$-0.03N/AN/A
Beta (Stock Volatility)0.89N/AN/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Clariene SE vs Orpea Stock Performance Analysis

Loading Price Chart...

Clariene SE
Orpea
Clariene SE Stock Overview | Orpea Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Clariene SE-0.33%-2.33%-9.29%-5.41%0.96%95.35%
Orpea-0.57%1.08%-14.15%15.76%18.23%100.49%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Clariene SE135.96%-45.10%-45.10%-45.10%-45.10%-45.10%
Orpea89.29%-98.30%-99.80%-99.73%-50.45%-50.45%

News Based Sentiment: Clariene SE vs Orpea

Clariene SE

News based Sentiment: MIXED

September presented a mixed bag for Clariane SE, with a significant earnings miss countered by a late-month stock recovery and continued analyst optimism. While the financial results were concerning, the company's commitment to innovation and positive analyst outlook suggest potential for future improvement, making it a cautiously watched investment.

View Clariene SE News Sentiment Analysis

Orpea

News based Sentiment: MIXED

September presented a mixed bag for Emeis, with positive H1 results countered by sharply contrasting analyst opinions and a reminder of past scandals. While the company is actively deleveraging and showing operational improvement, significant risks remain, making it a highly speculative investment.

View Orpea News Sentiment Analysis

Performance & Financial Health Analysis: Clariene SE vs Orpea

MetricCLARIORP
Market Information
Market Cap i€1.50B€1.94B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,242,599544,531
90 Day Avg. Volume i702,907398,436
Last Close€4.20€12.19
52 Week Range€1.49 - €5.51€4.44 - €15.11
% from 52W High-23.78%-19.32%
All-Time High€7.80 (Jun 12, 2023)€8,238.46 (Feb 17, 2020)
% from All-Time High-46.15%-99.85%
Growth Metrics
Quarterly Revenue Growth0.01%N/A
Quarterly Earnings GrowthN/AN/A
Financial Health
Profit Margin (TTM) i-0.01%0.79%
Operating Margin (TTM) i0.04%0.38%
Return on Equity (TTM) i-0.02%0.72%
Debt to Equity (MRQ) i209.584.85
Cash & Liquidity
Book Value per Share (MRQ)€10.08N/A
Cash per Share (MRQ)€2.13N/A
Operating Cash Flow (TTM) i€882.73M€-467,871,000
Levered Free Cash Flow (TTM) i€1.38B€1.35B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i€0.00€0.00

Valuation & Enterprise Metrics Analysis: Clariene SE vs Orpea

MetricCLARIORP
Price Ratios
P/E Ratio (TTM) i9.760.10
Forward P/E i53.0541.04
PEG Ratio i53.05N/A
Price to Sales (TTM) i0.290.37
Price to Book (MRQ) i0.42N/A
Market Capitalization
Market Capitalization i€1.50B€1.94B
Enterprise Value i€9.32B€10.46B
Enterprise Value Metrics
Enterprise to Revenue i1.762.01
Enterprise to EBITDA i7.142.94
Risk & Other Metrics
Beta i0.89N/A
Book Value per Share (MRQ) i€10.08N/A

Financial Statements Comparison: Clariene SE vs Orpea

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)CLARIORP
Revenue/Sales iN/AN/A
Cost of Goods Sold iN/AN/A
Gross Profit iN/AN/A
Research & Development iN/AN/A
Operating Income (EBIT) iN/AN/A
EBITDA iN/AN/A
Pre-Tax Income iN/AN/A
Income Tax iN/AN/A
Net Income (Profit) iN/AN/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)CLARIORP
Cash & Equivalents i€749.92M€644.95M
Total Current Assets i€2.09B€2.37B
Total Current Liabilities i€2.98B€3.12B
Long-Term Debt i€6.80B€7.86B
Total Shareholders Equity i€3.92B€1.89B
Retained Earnings iN/A€1.35B
Property, Plant & Equipment i€5.36B€11.30B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)CLARIORP
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCLARIORP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i1,242,599544,531
Average Daily Volume (90 Day) i702,907398,436
Shares Outstanding i355.72M159.12M
Float Shares i194.45MN/A
% Held by Insiders i0.31%N/A
% Held by Institutions i0.43%N/A

Dividend Analysis & Yield Comparison: Clariene SE vs Orpea

MetricCLARIORP
Last 12-Month Dividend i€0.00€0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i€0.08€0.00
3-Year Avg Dividend Yield i3.80%N/A
3-Year Total Dividends i€0.25€0.00
Ex-Dividend DateJun 21, 2023N/A